BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ACMELAB

All Eps Dividend Board Agm Q1 Q2 Q3

ACMELAB 17-Nov-2021

Trading of the shares of the Company will remain suspended on record date i.e., 18.11.2021.

ACMELAB 15-Nov-2021

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 16.11.2021 to 17.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 18.11.2021.

ACMELAB 14-Nov-2021

(Q1 Un-audited): EPS was Tk. 2.77 for July-September 2021 as against Tk. 1.96 for July-September 2020; NOCFPS was Tk. 3.77 for July-September 2021 as against Tk. 2.00 for July-September 2020. NAV per share was Tk. 97.83 as on September 30, 2021 and Tk. 95.04 as on June 30, 2021.

ACMELAB 08-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 11, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

ACMELAB 27-Oct-2021

The Company has informed that the Board of Directors has approved the revaluation of Property, Plant and Equipment's (Except Furniture & Fixture and Books & periodicals) of the Company conducted by an Independent valuer M/s. M M Rahman & Co., Chartered Accountants. Due to revaluation as at 30 June, 2021, value of Property, Plant and Equipment's, has been increased by BDT 15,137,594.00. Revaluation surplus will be accounted for in the Financial Statements for the year ended on 30 June, 2021.

ACMELAB 27-Oct-2021

There will be no price limit on the trading of the shares of the Company today (27.10.2021) following its corporate declaration.

ACMELAB 27-Oct-2021

The Board of Directors has recommended 25% cash dividend for the year ended on June 30, 2021. Date of AGM: 26.12.2021, Time: 11:30 AM, Venue: Digital Platform. Record Date: 18.11.2021. The Company has also reported EPS of Tk. 7.42, NAV per share of Tk. 95.04 and NOCFPS of Tk. 12.72 for the year ended on June 30, 2021 as against Tk. 6.85, Tk. 90.00 and Tk. 5.42 respectively for the same period of the previous year.

ACMELAB 21-Oct-2021

The Company has further informed that, the Board meeting under LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will now be held on October 26, 2021 at 4:00 PM instead of at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

ACMELAB 18-Oct-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2021 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

ACMELAB 28-Apr-2021

(Q3 Un-audited): EPS was Tk. 1.84 for January-March 2021 as against Tk. 1.68 for January-March 2020; EPS was Tk. 5.59 for July 2020-March 2021 as against Tk. 5.34 for July 2019-March 2020. NOCFPS was Tk. 7.52 for July 2020-March 2021 as against Tk. 3.97 for July 2019-March 2020. NAV per share was Tk. 93.11 as on March 31, 2021 and Tk. 90.00 as on June 30, 2020.

Previous Next page